Animal models of stroke: Translational potential at present and in 2050

Future Neurology

Volumn 9, Issue 5, 2014, Pages 541-551

  Herson, Paco S ^a   Traystman, Richard J ^a  

^a UNIVERSITY OF COLORADO SCHOOL OF MEDICINE   (United States)

Author keywords

animal models; basic science; clinical trial; ischemic stroke; neuroprotection

Indexed keywords

DISUFENTON SODIUM; INSULIN; TISSUE PLASMINOGEN ACTIVATOR;

AGING; BRAIN INFARCTION SIZE; BRAIN ISCHEMIA; CARDIOEMBOLIC STROKE; COMORBIDITY; CRANIECTOMY; DIABETES MELLITUS; DISEASE MODEL; EXPERIMENTAL STROKE; FIBRINOLYTIC THERAPY; FUNCTIONAL STATUS; HUMAN; HYPERGLYCEMIA; HYPERTENSION; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN TREATMENT; MIDDLE CEREBRAL ARTERY OCCLUSION; NERVE CELL PLASTICITY; NEUROPROTECTION; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; OBESITY; REVIEW; SEX DIFFERENCE; STUDY DESIGN; THROMBOEMBOLISM;

EID: 84908317864     PISSN: 14796708     EISSN: 17486971     Source Type: Journal    
DOI: 10.2217/fnl.14.44     Document Type: Review

References (96)

1. Furlan AJ. Challenges in acute ischemic stroke clinical trials. Cur. Cardiol. Rep. 14(6), 761-766 (2012
2. Furlan AJ. Recommendations for clinical trial evaluation of acute stroke therapies. Stroke 32(7), 1598-1606 (2001
3. Furlan AJ. Recommendations for standards regarding preclinical neuroprotective and restorative drug development. Stroke 30(12), 2752-2758 (1999
4. Saver JL, Albers GW, Dunn B, Johnston KC, Fisher M. Stroke Therapy Academic Industry Roundtable (STAIR) recommendations for extended window acute stroke therapy trials. Stroke 40(7), 2594-2600 (2009
5. Fisher M, Hanley DF, Howard G, Jauch EC, Warach S. Recommendations from the STAIR V meeting on acute stroke trials, technology and outcomes. Stroke 38(2), 245-248 (2007
6. O'Collins VE, Macleod MR, Donnan GA, Horky LL, Van Der Worp BH, Howells DW. 1,026 experimental treatments in acute stroke. Ann. Neurol. 59(3), 467-477 (2006
7. Dirnagl U, Lauritzen M. Improving the quality of biomedical research: guidelines for reporting experiments involving animals. J. Cereb. Blood Flow Metab. 31(4), 989-990 (2011
8. Vesterinen HM, Egan K, Deister A, Schlattmann P, Macleod MR, Dirnagl U. Systematic survey of the design, statistical analysis, and reporting of studies published in the 2008 volume of the Journal of Cerebral Blood Flow and Metabolism. J. Cereb. Blood Flow Metab. 31(4), 1064-1072 (2011
9. Macleod MR, Fisher M, O'Collins V et al. Reprint: good laboratory practice: preventing introduction of bias at the bench. J. Cereb. Blood Flow Metab. 29(2), 221-223 (2009
10. Howells DW, Sena ES, Macleod MR. Bringing rigour to translational medicine. Nat. Rev. Neurol. 10(1), 37-43 (2014
11. Macleod MR, Van Der Worp HB, Sena ES, Howells DW, Dirnagl U, Donnan GA. Evidence for the efficacy of NXY-059 in experimental focal cerebral ischaemia is confounded by study quality. Stroke 39(10), 2824-2829 (2008
12. Philip M, Benatar M, Fisher M, Savitz SI. Methodological quality of animal studies of neuroprotective agents currently in Phase II/III acute ischemic stroke trials. Stroke 40(2), 577-581 (2009
13. Tamura A, Graham DI, Mcculloch J, Teasdale GM. Focal cerebral ischaemia in the rat: 1. Description of technique and early neuropathological consequences following middle cerebral artery occlusion. J. Cereb. Blood Flow Metab. 1(1), 53-60 (1981
14. Tamura A, Asano T, Sano K, Tsumagari T, Nakajima A. Protection from cerebral ischemia by a new imidazole derivative (Y-9179) and pentobarbital. A comparative study in chronic middle cerebral artery occlusion in cats. Stroke 10(2), 126-134 (1979
15. Crowell RM, Marcoux FW, Degirolami U. Variability and reversibility of focal cerebral ischemia in unanesthetized monkeys. Neurology 31(10), 1295-1302 (1981
16. Markgraf CG, Kraydieh S, Prado R, Watson BD, Dietrich WD, Ginsberg MD. Comparative histopathologic consequences of photothrombotic occlusion of the distal middle cerebral artery in Sprague-Dawley and Wistar rats. Stroke 24(2), 286-292 (1993
17. Hofmeijer J, Kappelle LJ, Algra A, Amelink GJ, Van Gijn J, Van Der Worp HB. Surgical decompression for space-occupying cerebral infarction (the Hemicraniectomy After Middle Cerebral Artery infarction with Life-threatening Edema Trial [HAMLET]): a multicentre, open, randomised trial. Lancet Neurol. 8(4), 326-333 (2009
18. Barone FC, Knudsen DJ, Nelson AH, Feuerstein GZ, Willette RN. Mouse strain differences in susceptibility to cerebral ischemia are related to cerebral vascular anatomy. J. Cereb. Blood Flow Metab. 13(4), 683-692 (1993
19. Longa EZ, Weinstein PR, Carlson S, Cummins R. Reversible middle cerebral artery occlusion without craniectomy in rats. Stroke 20(1), 84-91 (1989
20. Gao H, Liu Y, Lu S, Xiang B, Wang C. A reversible middle cerebral artery occlusion model using intraluminal balloon technique in monkeys. J. Stroke Cereb. Dis. 15(5), 202-208 (2006
21. Moskowitz MA, Lo EH, Iadecola C. The science of stroke: mechanisms in search of treatments. Neuron 67(2), 181-198 (2010
22. Lam CK, Yoo T, Hiner B, Liu Z, Grutzendler J. Embolus extravasation is an alternative mechanism for cerebral microvascular recanalization. Nature 465(7297), 478-482 (2010
23. Kudo M, Aoyama A, Ichimori S, Fukunaga N. An animal model of cerebral infarction. Homologous blood clot emboli in rats. Stroke 13(4), 505-508 (1982
24. Niessen F, Hilger T, Hoehn M, Hossmann KA. Differences in clot preparation determine outcome of recombinant tissue plasminogen activator treatment in experimental thromboembolic stroke. Stroke 34(8), 2019-2024 (2003
25. Howells DW, Porritt MJ, Rewell SS et al. Different strokes for different folks: the rich diversity of animal models of focal cerebral ischemia. J. Cereb. Blood Flow Metab. 30(8), 1412-1431 (2010
26. O'Donnell MJ, Xavier D, Liu L et al. Risk factors for ischaemic and intracerebral haemorrhagic stroke in 22 countries (the INTERSTROKE study): a case-control study. Lancet 376(9735), 112-123 (2010
27. Lloyd-Jones D, Adams RJ, Brown TM et al. Heart disease and stroke statistics - 2010 update: a report from the American Heart Association. Circulation 121(7), e46-e215 (2010
28. Badan I, Buchhold B, Hamm A et al. Accelerated glial reactivity to stroke in aged rats correlates with reduced functional recovery. J. Cereb. Blood Flow Metab. 23(7), 845-854 (2003
29. Ay H, Koroshetz WJ, Vangel M et al. Conversion of ischemic brain tissue into infarction increases with age. Stroke 36(12), 2632-2636 (2005
30. Popa-Wagner A, Buga AM, Kokaia Z. Perturbed cellular response to brain injury during aging. Ageing Res. Rev. 10(1), 71-79 (2011
31. Cheng J, Hu W, Toung TJ et al. Age-dependent effects of testosterone in experimental stroke. J. Cereb. Blood Flow Metab. 29(3), 486-494 (2009
32. Sierra C, Coca A, Schiffrin EL. Vascular mechanisms in the pathogenesis of stroke. Curr. Hypertens. Rep. 13(3), 200-207 (2011
33. Lawes CM, Bennett DA, Feigin VL, Rodgers A. Blood pressure and stroke: an overview of published reviews. Stroke 35(4), 1024 (2004
34. Furie KL, Kasner SE, Adams RJ et al. Guidelines for the prevention of stroke in patients with stroke or transient ischemic attack: a guideline for healthcare professionals from the American Heart Association/ American Stroke Association. Stroke 42(1), 227-276 (2011
35. O'Collins VE, Donnan GA, Macleod MR, Howells DW. Hypertension and experimental stroke therapies. J. Cereb. Blood Flow Metab. 33(8), 1141-1147 (2013
36. Fredriksson K, Kalimo H, Nordborg C, Johansson BB, Olsson Y. Nerve cell injury in the brain of stroke-prone spontaneously hypertensive rats. Acta Neuropathol. 76(3), 227-237 (1988
37. Barone FC, Price WJ, White RF, Willette RN, Feuerstein GZ. Genetic hypertension and increased susceptibility to cerebral ischemia. Neurosci. Biobehav. Rev. 16(2), 219-233 (1992
38. Intengan HD, Schiffrin EL. Structure and mechanical properties of resistance arteries in hypertension: role of adhesion molecules and extracellular matrix determinants. Hypertension 36(3), 312-318 (2000
39. Jimenez-Altayo F, Martin A, Rojas S et al. Transient middle cerebral artery occlusion causes different structural, mechanical, and myogenic alterations in normotensive and hypertensive rats. Am. J. Physiol. Heart Circ. Physiol. 293(1), H628-H635 (2007
40. Pires PW, Dams Ramos CM, Matin N, Dorrance AM. The effects of hypertension on the cerebral circulation. Am. J. Physiol. Heart Circ. Physiol. 304(12), H1598-H1614 (2013
41. Harrison DG, Marvar PJ, Titze JM. Vascular inflammatory cells in hypertension. Front. Physiol. 3, 128 (2012
42. Zhou J, Ando H, Macova M, Dou J, Saavedra JM. Angiotensin II AT1 receptor blockade abolishes brain microvascular inflammation and heat shock protein responses in hypertensive rats. J. Cereb. Blood Flow Metab. 25(7), 878-886 (2005
43. Zubcevic J, Waki H, Raizada MK, Paton JF. Autonomic-immune-vascular interaction: an emerging concept for neurogenic hypertension. Hypertension 57(6), 1026-1033 (2011
44. Touyz RM, Briones AM. Reactive oxygen species and vascular biology: implications in human hypertension. Hypertens. Res. 34(1), 5-14 (2011
45. Bright R, Steinberg GK, Mochly-Rosen D. DeltaPKC mediates microcerebrovascular dysfunction in acute ischemia and in chronic hypertensive stress in vivo. Brain Res. 1144, 146-155 (2007
46. Fujishima M, Onoyama K, Oniki H, Ogata J, Omae T. Effects of acute hypertension on brain metabolism in normotensive, renovascular hypertensive and spontaneously hypertensive rats. Stroke 9(4), 349-353 (1978
47. Briones AM, Touyz RM. Oxidative stress and hypertension: current concepts. Curr. Hypertens. Rep. 12(2), 135-142 (2010
48. Ritz MF, Grond-Ginsbach C, Engelter S, Lyrer P. Gene expression suggests spontaneously hypertensive rats may have altered metabolism and reduced hypoxic tolerance. Curr. Neurovasc. Res. 9(1), 10-19 (2012
49. Qiu J, Hong Q, Chen RH et al. Gene expression profiles in the prefrontal cortex of SHR rats by cDNA microarrays. Mol. Biol. Rep. 37(4), 1733-1740 (2010
50. Ferrari MF, Reis EM, Matsumoto JP, Fior-Chadi DR. Gene expression profiling of cultured cells from brainstem of newborn spontaneously hypertensive and Wistar Kyoto rats. Cell. Mol. Neurobiol. 29(3), 287-308 (2009
51. Ishida H, Takemori K, Dote K, Ito H. Expression of glucose transporter-1 and aquaporin-4 in the cerebral cortex of stroke-prone spontaneously hypertensive rats in relation to the blood-brain barrier function. Am. J. Hypertens. 19(1), 33-39 (2006
52. Yamagata K, Tagami M, Yamori Y Neuronal vulnerability of stroke-prone spontaneously hypertensive rats to ischemia and its prevention with antioxidants such as vitamin E. Neuroscience 170(1), 1-7 (2010
53. Kaarisalo MM, Raiha I, Sivenius J et al. Diabetes worsens the outcome of acute ischemic stroke. Diabetes Res. Clin. Pract. 69(3), 293-298 (2005
54. Williams LS, Rotich J, Qi R et al. Effects of admission hyperglycemia on mortality and costs in acute ischemic stroke. Neurology 59(1), 67-71 (2002
55. King AJ. The use of animal models in diabetes research. Br. J. Pharmacol. 166(3), 877-894 (2012
56. Liu L, Wang Z, Wang X et al. Comparison of two rat models of cerebral ischemia under hyperglycemic conditions. Microsurgery 27(4), 258-262 (2007
57. Huang NC, Wei J, Quast MJ. A comparison of the early development of ischemic brain damage in normoglycemic and hyperglycemic rats using magnetic resonance imaging. Exp. Brain Res. 109(1), 33-42 (1996
58. De Courten-Myers GM, Kleinholz M, Wagner KR, Myers RE. Fatal strokes in hyperglycemic cats. Stroke 20(12), 1707-1715 (1989
59. Palmon SC, Sieber FE, Brown PR, Koehler RC, Eleff SM, Traystman RJ. Poor hemodynamic and metabolic recovery after global incomplete cerebral ischemia associated with short-term diabetes in dogs. J. Cereb. Blood Flow Metab. 15(4), 673-680 (1995
60. Kraft SA, Larson CP Jr, Shuer LM, Steinberg GK, Benson GV, Pearl RG. Effect of hyperglycemia on neuronal changes in a rabbit model of focal cerebral ischemia. Stroke 21(3), 447-450 (1990
61. Dietrich WD, Alonso O, Busto R. Moderate hyperglycemia worsens acute blood-brain barrier injury after forebrain ischemia in rats. Stroke 24(1), 111-116 (1993
62. Vannucci SJ, Willing LB, Goto S et al. Experimental stroke in the female diabetic, db/db, mouse. J. Cereb. Blood Flow Metab. 21(1), 52-60 (2001
63. Siesjo BK, Katsura KI, Kristian T, Li PA, Siesjo P. Molecular mechanisms of acidosis-mediated damage. Acta Neurochir. Suppl. 66, 8-14 (1996
64. Kurihara J, Katsura K, Siesjo BK, Wieloch T. Hyperglycemia and hypercapnia differently affect post-ischemic changes in protein kinases and protein phosphorylation in the rat cingulate cortex. Brain Res. 995(2), 218-225 (2004
65. Kawai N, Keep RF, Betz AL, Nagao S. Hyperglycemia induces progressive changes in the cerebral microvasculature and blood-brain barrier transport during focal cerebral ischemia. Acta Neurochir. Suppl. 71, 219-221 (1998
66. Kamada H, Yu F, Nito C, Chan PH. Influence of hyperglycemia on oxidative stress and matrix metalloproteinase-9 activation after focal cerebral ischemia/reperfusion in rats: relation to blood-brain barrier dysfunction. Stroke 38(3), 1044-1049 (2007
67. Kittaka M, Wang L, Sun N et al. Brain capillary tissue plasminogen activator in a diabetes stroke model. Stroke 27(4), 712-719 (1996
68. Panes J, Kurose I, Rodriguez-Vaca D et al. Diabetes exacerbates inflammatory responses to ischemia-reperfusion. Circulation 93(1), 161-167 (1996
69. Ding C, He Q, Li PA. Diabetes increases expression of ICAM after a brief period of cerebral ischemia. J. Neuroimmunol. 161(1-2), 61-67 (2005
70. Li Q, Atochin D, Kashiwagi S et al. Deficient eNOS phosphorylation is a mechanism for diabetic vascular dysfunction contributing to increased stroke size. Stroke 44(11), 3183-3188 (2013
71. Schofield I, Malik R, Izzard A, Austin C, Heagerty A. Vascular structural and functional changes in Type 2 diabetes mellitus: evidence for the roles of abnormal myogenic responsiveness and dyslipidemia. Circulation 106(24), 3037-3043 (2002
72. Onodera H, Oshio K, Uchida M, Tanaka Y, Hashimoto T. Analysis of intracranial pressure pulse waveform and brain capillary morphology in Type 2 diabetes mellitus rats. Brain Res. 1460, 73-77 (2012
73. Hou Q, Zuo Z, Michel P et al. Influence of chronic hyperglycemia on cerebral microvascular remodeling: an in vivo study using perfusion computed tomography in acute ischemic stroke patients. Stroke 44(12), 3557-3560. (2013
74. Toung TK, Hurn PD, Traystman RJ, Sieber FE. Estrogen decreases infarct size after temporary focal ischemia in a genetic model of Type 1 diabetes mellitus. Stroke 31(11), 2701-2706 (2000
75. Lemay DR, Gehua L, Zelenock GB, D'alecy LG. Insulin administration protects neurologic function in cerebral ischemia in rats. Stroke 19(11), 1411-1419 (1988
76. Warner DS, Gionet TX, Todd MM, Mcallister AM. Insulin-induced normoglycemia improves ischemic outcome in hyperglycemic rats. Stroke 23(12), 1775-1780 (1992
77. Hamilton MG, Tranmer BI, Auer RN. Insulin reduction of cerebral infarction due to transient focal ischemia. J. Neurosurg. 82(2), 262-268 (1995
78. Huang SS, Lu YJ, Huang JP, Wu YT, Day YJ, Hung LM. The essential role of endothelial nitric oxide synthase activation in insulin-mediated neuroprotection against ischemic stroke in diabetes. J. Vasc. Surg. 59(2), 483-491 (2013
79. Voll CL, Auer RN. Insulin attenuates ischemic brain damage independent of its hypoglycemic effect. J. Cereb. Blood Flow Metab. 11(6), 1006-1014 (1991
80. Philpott KL, Mccarthy MJ, Klippel A, Rubin LL. Activated phosphatidylinositol 3-kinase and Akt kinase promote survival of superior cervical neurons. J. Cell Biol. 139(3), 809-815 (1997
81. Sanderson TH, Kumar R, Murariu-Dobrin AC, Page AB, Krause GS, Sullivan JM. Insulin activates the PI3K-Akt survival pathway in vulnerable neurons following global brain ischemia. Neurol. Res. 31(9), 947-958 (2009
82. Mielke JG, Wang YT. Insulin exerts neuroprotection by counteracting the decrease in cell-surface GABA receptors following oxygen-glucose deprivation in cultured cortical neurons. J. Neurochem. 92(1), 103-113 (2005
83. Nelson TJ, Sun MK, Hongpaisan J, Alkon DL. Insulin, PKC signaling pathways and synaptic remodeling during memory storage and neuronal repair. Eur. J. Pharmacol. 585(1), 76-87 (2008
84. Zhao WQ, Alkon DL. Role of insulin and insulin receptor in learning and memory. Mol. Cell. Endocrinol. 177(1-2), 125-134 (2001
85. Mckay MK, Hester RL. Role of nitric oxide, adenosine, and ATP-sensitive potassium channels in insulin-induced vasodilation. Hypertension 28(2), 202-208 (1996
86. Appelros P, Stegmayr B, Terent A. Sex differences in stroke epidemiology: a systematic review. Stroke 40(4), 1082-1090 (2009
87. Reeves MJ, Bushnell CD, Howard G et al. Sex differences in stroke: epidemiology, clinical presentation, medical care, and outcomes. Lancet Neurol. 7(10), 915-926 (2008
88. Alkayed NJ, Harukuni I, Kimes AS, London ED, Traystman RJ, Hurn PD. Gender-linked brain injury in experimental stroke. Stroke 29(1), 159-165 (1998
89. Yamori Y, Horie R, Handa H, Sato M, Fukase M. Pathogenetic similarity of strokes in stroke-prone spontaneously hypertensive rats and humans. Stroke 7(1), 46-53 (1976
90. Herson PS, Hurn PD. Gender and the injured brain. Prog. Brain Res. 186, 177-187 (2010
91. Lang JT, Mccullough LD. Pathways to ischemic neuronal cell death: are sex differences relevant?. J. Transl. Med. 6, 33 (2008
92. Manwani B, Liu F, Xu Y, Persky R, Li J, Mccullough LD. Functional recovery in aging mice after experimental stroke. Brain Behav. Immun. 25(8), 1689-1700 (2011
93. Herson PS, Palmateer J, Hurn PD, Devries AC. Evaluating behavioral outcomes from ischemic brain injury (Chapter 12). In: Translational Animal Models of Behavioral Analysis. Raber J (Ed.). Humana Press, NY, USA, 307-328 (2010
94. Hofmeijer J, Van Putten MJ. Ischemic cerebral damage: an appraisal of synaptic failure. Stroke 43(2), 607-615 (2012
95. Clarkson AN, Huang BS, Macisaac SE, Mody I, Carmichael ST. Reducing excessive GABA-mediated tonic inhibition promotes functional recovery after stroke. Nature 468(7321), 305-309 (2010
96. Carmichael ST. Brain excitability in stroke: the yin and yang of stroke progression. Arch. Neurol. 69(2), 161-167 (2012